Items where Author is "Babu, S."

Article

Pavan Kumar, N and Nancy, P and Hissar, S and Sivakumar, S and Viswanathan, V and Bethunaickan, R and Kornfeld, H and Babu, S. (2026) Complement profiling for treatment outcomes in pulmonary TB. Complement profiling for treatment outcomes in pulmonary TB, 17 (167994). pp. 1-10.

Subramanian, N and Philip, P and Rajamanickam, A and Pavan Kumar, N and Babu, S. and Narayanan, M (2025) Delineating markers of disease-disease interaction: a systematic methodology and its application to multiple diabetes-helminth cohorts. Delineating markers of disease-disease interaction: a systematic methodology and its application to multiple diabetes-helminth cohorts, 26 (272).

Dasan, B and Munisankar, S and Kumar, NP and Moideen, K. and Pandiarajan, AN and Nott, S and Viswanathan, V and Shanmugam, S and Hissar, S and Thiruvengadam, K. and Kornfeld, H and Babu, S. (2025) Impact of cytomegalovirus exposure on disease severity, bacterial burden, immune responses and treatment outcomes in tuberculosis. Impact of cytomegalovirus exposure on disease severity, bacterial burden, immune responses and treatment outcomes in tuberculosis, 16 (161270).

Pavan Kumar, N and Hissar, S and Nancy, A and Thiruvengadam, K. and Banurekha, VV and Balaji, S and Elilarasi, S and Gomathi, N S and Ganesh, J and Aravind, MA and Baskaran, D and Swaminathan, S and Babu, S. (2025) Plasma Matrix Metalloproteinases Signature as Biomarkers for Pediatric Tuberculosis Diagnosis: A Prospective Case–Control Study. Plasma Matrix Metalloproteinases Signature as Biomarkers for Pediatric Tuberculosis Diagnosis: A Prospective Case–Control Study, 13(6) (171).

Pavan Kumar, N and Rajamariyam, M and Nancy, A and Kumar, BS and Janakiram, M and Ahamed, SF and Kumar, V and Vijila, S and Sekar, S and Kuralmozhi, R and Baskaran, D and Hissar, S and Babu, S. (2025) Acute-phase proteins as biomarkers of inflammation in HIV patients with latent tuberculosis: a prospective study. Acute-phase proteins as biomarkers of inflammation in HIV patients with latent tuberculosis: a prospective study, 16 (155177).

Nancy Pandiarajan, A and Kumar, N P and Moideen, K. and Thiruvengadam, K. and Hissar, S and Sivakumar, S and Bethunaickan, R and Viswanathan, V and Kornfeld, Hardy and Babu, S. (2025) Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment Outcomes. Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment Outcomes, 14(2) (146). pp. 1-14.

Kumar, NP and Balaji, S and Devi, PG and Ramraj, B and Nancy, A and Selvaraj, N and Ahamed, SF and Gunasundari, A and Seetha, A and Varadarajan, P and Venkataraman, A and Babu, S. (2024) Inflammatory cytokine responses in pediatric tuberculosis with or without SARS-CoV-2 seropositivity. Inflammatory cytokine responses in pediatric tuberculosis with or without SARS-CoV-2 seropositivity, 89(6 (106314).

Pandiarajan, AN and Kumar, NP and Rajamanickam, A and Bhavani, PK and Jeyadeepa, B and Selvaraj, N and Asokan, D and Tripathy, S and Padmapriyadarsini, C and Babu, S. (2024) Enhanced Antimicrobial Peptide Response Following Bacillus Calmette–Guerin Vaccination in Elderly Individuals. Enhanced Antimicrobial Peptide Response Following Bacillus Calmette–Guerin Vaccination in Elderly Individuals, 12(9) (1065).

Rajamanickam, A and Kothandaraman, SP and Kumar, NP and Viswanathan, V and Shanmugam, S and Hissar, S and Nott, S and Kornfeld, H and Babu, S. (2024) Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes. Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes, 29(15) (144716).

Rajamanickam, A and Babu, S. (2024) Helminth Infections and Diabetes: Mechanisms Accounting for Risk Amelioration. Helminth Infections and Diabetes: Mechanisms Accounting for Risk Amelioration, 44(1) (339-55).

Nathella, PK and Padmapriyadarsini, C and Nancy, A and Karunanithi, K and Selvaraj, N and Renji, RM and Shrinivasa, BM and Babu, S. (2024) BCG vaccination is associated with longitudinal changes in systemic eicosanoid levels in elderly individuals: A secondary outcome analysis. BCG vaccination is associated with longitudinal changes in systemic eicosanoid levels in elderly individuals: A secondary outcome analysis, 10(12) (e32643).

Rajamanickam, A and Dasan, B and Munisankar, S and Nott, S and Menon, P A and Ahamed Shaik, P and Chinnaiyan, P and Nutman, TB and Babu, S. (2024) Impact of Strongyloides stercoralis infection on complementactivation in Type 2 diabetes mellitus: Insights from a clinical and anthelmintic intervention study. Impact of Strongyloides stercoralis infection on complementactivation in Type 2 diabetes mellitus: Insights from a clinical and anthelmintic intervention study, 18(4) (e00120).

Rajamanickam, A and Nathella, PK and Venkataraman, A and Chandrasekaran, P. and Rajendraprasath, S and Devaleenal, D Bella and Pandiarajan, AN and Krishnakumar, G and Venkat Ramanan, P and Babu, S. (2024) Elucidating systemic immune responses to acute and convalescent SARS‐CoV‐2 infection in children and elderly individuals. Elucidating systemic immune responses to acute and convalescent SARS‐CoV‐2 infection in children and elderly individuals, 12 (e1167).

Kathamuthu, G. R. and Moideen, K. and Baskaran, D. and Sekar, G. and Rathinam, S. and Bharathi, V. J. and Ganeshan, G. R. and Babu, S. (2018) Tuberculous lymphadenitis is associated with altered levels of circulating angiogenic factors. The International Journal of Tuberculosis and Lung Disease, 22 (5). pp. 557-566. ISSN 1027-3719

Kumar, N. P. and Velayutham, B. and Nair, D. and Babu, S. (2017) Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease, 21 (1). pp. 93-99. ISSN 1027-3719

Babu, S. and Nutman, T. B. (2014) Immunology of lymphatic filariasis. Parasite Immunology, 36 (8). pp. 338-346. ISSN 01419838

Balasubramanian, S and Rajamanickam, A and Munisankar, S and Menon, P A and Babu, S. Relative contribution of biomedical, demographic, and socioeconomic factors to COVID-19 vaccine receipt in rural India. Relative contribution of biomedical, demographic, and socioeconomic factors to COVID-19 vaccine receipt in rural India, 19(6) (e03058).